Clinical Trial Results: Positive or negative data from OCFT's clinical trials for its drug candidates can significantly impact stock price.

Regulatory Approvals: FDA approval of OCFT's products usually causes a price surge, while rejection leads to a drop.

Financial Performance: Revenue, earnings, and profitability reports greatly influence investor sentiment and stock valuation.

Market Conditions: Overall market trends and investor risk appetite can affect OCFT’s stock price, especially during economic downturns.

Competition: The competitive landscape, including competing products and companies, impacts market share and investor perception.

Partnerships and Collaborations: Strategic alliances and partnerships often boost investor confidence and drive stock price increases.

Management Changes: Key leadership changes or announcements can create uncertainty or optimism, affecting the stock.

Debt Levels: High debt can make investors bearish, affecting the stock negatively.

Cash Position: Good cash flow helps the company innovate which could lead to positive stock impacts.

Intellectual Property: Patent status and protection influence long-term value of the company.